21-46122932-G-C
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_001849.4(COL6A2):c.1666G>C(p.Glu556Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,978 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E556K) has been classified as Uncertain significance.
Frequency
Consequence
NM_001849.4 missense
Scores
Clinical Significance
Conservation
Publications
- collagen 6-related myopathyInheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
- Ullrich congenital muscular dystrophy 1BInheritance: AR, AD Classification: DEFINITIVE Submitted by: G2P
- Bethlem myopathy 1AInheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp
- Ullrich congenital muscular dystrophy 1AInheritance: AD, AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- myosclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL6A2 | NM_001849.4 | c.1666G>C | p.Glu556Gln | missense_variant | Exon 21 of 28 | ENST00000300527.9 | NP_001840.3 | |
| COL6A2 | NM_058174.3 | c.1666G>C | p.Glu556Gln | missense_variant | Exon 21 of 28 | ENST00000397763.6 | NP_478054.2 | |
| COL6A2 | NM_058175.3 | c.1666G>C | p.Glu556Gln | missense_variant | Exon 21 of 28 | NP_478055.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL6A2 | ENST00000300527.9 | c.1666G>C | p.Glu556Gln | missense_variant | Exon 21 of 28 | 1 | NM_001849.4 | ENSP00000300527.4 | ||
| COL6A2 | ENST00000397763.6 | c.1666G>C | p.Glu556Gln | missense_variant | Exon 21 of 28 | 5 | NM_058174.3 | ENSP00000380870.1 | ||
| COL6A2 | ENST00000409416.6 | c.1666G>C | p.Glu556Gln | missense_variant | Exon 20 of 27 | 5 | ENSP00000387115.1 | |||
| COL6A2 | ENST00000413758.1 | c.289G>C | p.Glu97Gln | missense_variant | Exon 6 of 11 | 3 | ENSP00000395751.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460978Hom.: 0 Cov.: 36 AF XY: 0.00000275 AC XY: 2AN XY: 726802 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1666G>C (p.E556Q) alteration is located in exon 21 (coding exon 20) of the COL6A2 gene. This alteration results from a G to C substitution at nucleotide position 1666, causing the glutamic acid (E) at amino acid position 556 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Bethlem myopathy 1A Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 556 of the COL6A2 protein (p.Glu556Gln). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with COL6A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1878703). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt COL6A2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
not provided Uncertain:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at